Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Double-blind Parallel Group Trial to Study the Effects of an Infant Formula and a follow-on Formula Containing Bio-active Ingredients on Growth, Tolerance and Infections in Healthy Term Infants

NCT06137235 is registered in ClinicalTrials.gov with FrieslandCampina as lead sponsor.

NCT NCT06137235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06137235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Double-blind Parallel Group Trial to Study the Effects of an Infant Formula and a follow-on Formula Containing Bio-active Ingredients on Growth, Tolerance and Infections in Healthy Term Infants
Lead sponsor
FrieslandCampina
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 18, 2023
Completion date
December 31, 2027
Enrollment
456 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

growth, infections